<DOC>
	<DOCNO>NCT01010334</DOCNO>
	<brief_summary>Patient choose either receive standard care accord National Comprehensive Cancer Network ( NCCN ) approve guideline condition treat accord one arm protocol could enrol . The selection arm physician discretion .</brief_summary>
	<brief_title>Comparison Standard Care Treatment Protocol</brief_title>
	<detailed_description>All patient fail enroll specific therapeutic research protocol use FDA approve drug CTMS accept therapy screen study . Patients randomize ( Patient choice ) either standard care describe NCCN guideline publish peer-reviewed phase II III study show efficacy one arm protocol fail enroll , determine treat physician .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Skin Neoplasms</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Patients must cancer require chemotherapy radiotherapy Inability comply study and/or followup procedure Any contraindication per FDA notice select drug Pregnant ( positive pregnancy test ) lactating . No effective mean contraception ( men woman ) subject childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>INST 0813</keyword>
	<keyword>Standard Care</keyword>
</DOC>